MARKETLETTER ON-LINE DAILY
While the weekly, printed copy of the Marketletter is generally considered to be the most useful form of news, for those who can't wait, there is also the possibility of plugging into an on-line service (via Data-Star), to pick up news as it is written on a daily basis. Marketletter is also available on-line with Predicasts (Information Access).
Looking at stories daily not only allows subscribers to see what is being published on all aspects of the pharmaceutical industry, it also permits a pre-publication view of what is being said about their own companies; this means it is possible to "add a little more" to what Marketletter is saying.
Telephone contacts for Data-Star: UK +44 71 930 5503; Switzerland +41 31 384 9500; Germany +49 6944 4063; France +33 1 46 67 7878; Italy +39 6 3244419; Scandinavia +46 31 83 5975; Japan +81 3 3439 0123; Korea (82-2) 220 7270; Australia +61 2 212 2867; USA & Canada (toll free) 800 221 7754.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze